228 related articles for article (PubMed ID: 8639804)
1. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.
Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea AD
Blood; 1996 May; 87(10):4424-32. PubMed ID: 8639804
[TBL] [Abstract][Full Text] [Related]
2. The Fanconi anemia polypeptide FACC is localized to the cytoplasm.
Yamashita T; Barber DL; Zhu Y; Wu N; D'Andrea AD
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6712-6. PubMed ID: 7517562
[TBL] [Abstract][Full Text] [Related]
3. Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.
Pulsipher M; Kupfer GM; Naf D; Suliman A; Lee JS; Jakobs P; Grompe M; Joenje H; Sieff C; Guinan E; Mulligan R; D'Andrea AD
Mol Med; 1998 Jul; 4(7):468-79. PubMed ID: 9713825
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension.
Joenje H; Youssoufian H; Kruyt FA; dos Santos CC; Wevrick R; Buchwald M
Blood Cells Mol Dis; 1995; 21(3):182-91. PubMed ID: 8673470
[TBL] [Abstract][Full Text] [Related]
5. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
6. MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.
Li Y; Youssoufian H
J Clin Invest; 1997 Dec; 100(11):2873-80. PubMed ID: 9389754
[TBL] [Abstract][Full Text] [Related]
7. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
[TBL] [Abstract][Full Text] [Related]
8. Induction of Fanconi anemia cellular phenotype in human 293 cells by overexpression of a mutant FAC allele.
Youssoufian H; Li Y; Martin ME; Buchwald M
J Clin Invest; 1996 Feb; 97(4):957-62. PubMed ID: 8613549
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
10. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
[TBL] [Abstract][Full Text] [Related]
11. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
12. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2.
Kupfer GM; Yamashita T; Naf D; Suliman A; Asano S; D'Andrea AD
Blood; 1997 Aug; 90(3):1047-54. PubMed ID: 9242535
[TBL] [Abstract][Full Text] [Related]
13. The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.
Futaki M; Yamashita T; Yagasaki H; Toda T; Yabe M; Kato S; Asano S; Nakahata T
Blood; 2000 Feb; 95(4):1493-8. PubMed ID: 10666230
[TBL] [Abstract][Full Text] [Related]
14. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
[TBL] [Abstract][Full Text] [Related]
15. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.
Lo Ten Foe JR; Rooimans MA; Bosnoyan-Collins L; Alon N; Wijker M; Parker L; Lightfoot J; Carreau M; Callen DF; Savoia A; Cheng NC; van Berkel CG; Strunk MH; Gille JJ; Pals G; Kruyt FA; Pronk JC; Arwert F; Buchwald M; Joenje H
Nat Genet; 1996 Nov; 14(3):320-3. PubMed ID: 8896563
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.
Rathbun RK; Faulkner GR; Ostroski MH; Christianson TA; Hughes G; Jones G; Cahn R; Maziarz R; Royle G; Keeble W; Heinrich MC; Grompe M; Tower PA; Bagby GC
Blood; 1997 Aug; 90(3):974-85. PubMed ID: 9242526
[TBL] [Abstract][Full Text] [Related]
18. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
Kupfer GM; D'Andrea AD
Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
[TBL] [Abstract][Full Text] [Related]
19. A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein.
Gavish H; dos Santos CC; Buchwald M
Hum Mol Genet; 1993 Feb; 2(2):123-6. PubMed ID: 8499901
[TBL] [Abstract][Full Text] [Related]
20. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
